Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2019 | Story Xolisa Mnukwa | Photo Xolisa Mnukwa
DOTY
From the left; Gift Taku, 2019 Doty winner; Reabetswe Mabine, Doty Coordinator Tshepo Zweni, first runner-up and Jacobeth Selinga, second runner-up

The votes have been tallied, and after much deliberation, the UFS is proud to announce Gift Taku as the winner of the 2019 KovsieGear Designer of the Year (DOTY) Competition!

Tshepo Zwane and Jacobeth Selinga won second and third place respectively, with innovative designs that complied with the assessment requirements, based on originality of the design, adherence to the brand guidelines, creativity, and other criteria.

Gift’s design triumphed with 845 votes on the UFS KovsieLife webpage, as well as in the presentation in front of a judging panel.

Since 2016, KovsieGear has been discovering local (UFS staff and students) graphic designers and giving them a platform to showcase their work through DOTY, which runs annually. The aim of the competition is to support local talent by giving entrants an opportunity to come up with creative designs that are unique to the university and which will be used on limited-edition apparel in the store, as well as getting featured in the KovsieGear catalogue.

The competition has since fashioned the best clothing-logo designs the university has ever seen and continues to motivate and empower students to make positive contributions to the Kovsie campus culture and brand.


For more information about DOTY contact Reabetswe Mabine at MabineR@ufs.ac.za 

The winning design by Gift Taku:

Gift design

News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.

Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept